WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2001087971) A NOVEL POLYPEPTIDE, HUMAN RIBOSOMAL PROTEIN S18-14 AND THE POLYNUCLEOTIDE ENCODING THEREOF
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2001/087971    International Application No.:    PCT/CN2001/000727
Publication Date: 22.11.2001 International Filing Date: 08.05.2001
IPC:
A61K 38/00 (2006.01), C07K 14/47 (2006.01)
Applicants: SHANGHAI BIOWINDOW GENE DEVELOPMENT INC. [CN/CN]; 12th Floor 3rd Building 1111 Zhongshan Bei Er Road Shanghai 200092 (CN) (For All Designated States Except US).
MAO, Yumin [CN/CN]; (CN) (For US Only).
XIE, Yi [CN/CN]; (CN) (For US Only)
Inventors: MAO, Yumin; (CN).
XIE, Yi; (CN)
Agent: SHANGHAI HUA DONG PATENT AGENCY; 319 Yue Yang Road Shanghai 200031 (CN)
Priority Data:
00 1 15636.5 09.05.2000 CN
Title (EN) A NOVEL POLYPEPTIDE, HUMAN RIBOSOMAL PROTEIN S18-14 AND THE POLYNUCLEOTIDE ENCODING THEREOF
(FR) PROTEINE S18-14 RIBOSOMALE, POLYPEPTIDE HUMAIN, ET POLYNUCLEOTIDE LA CODANT
Abstract: front page image
(EN)The invention discloses a novel polypeptide, human ribosomal protein S18-14, the polynucleotide encoding the same and the method of production thereof by DNA recombinant techniques. Methods of using the polypeptide for treating various diseases such as malignant tumors, hemopathy, HIV infection, immune diseases, and various inflammations are also disclosed. Furthermore, the invention discloses the antagonists of the polypeptide and the effects thereof. The use of the polynucleotide encoding the novel human ribosomal protein S18-14 is also disclosed.
(FR)L'invention concerne un polypeptide humain, une protéine S18-14 ribosomale, le polynucléotide qui le code et un procédé de production de ce polypeptide à l'aide de technologies de recombinaison de l'ADN. Elle concerne aussi des méthodes d'utilisation du polypeptide pour le traitement de troubles variés, tels que tumeurs malignes, hémopathie, infection VIH, maladies immunologiques, et inflammations variées. Elle concerne encore les antagonistes du polypeptide et leurs effets. Elle concerne enfin l'utilisation du polynucléotide codant la protéine S18-14 ribosomale humaine.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CO, CR, CU, CZ, DE, DK, DM, DZ, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: Chinese (ZH)
Filing Language: Chinese (ZH)